Dashboard
1
Poor Management Efficiency with a low ROE of 7.92%
- The company has been able to generate a Return on Equity (avg) of 7.92% signifying low profitability per unit of shareholders funds
2
Healthy long term growth as Net Sales has grown by an annual rate of 60.53%
3
The company declared positive results in Dec'24 after negative results in Jun'24
4
With ROE of 34.84%, it has a Expensive valuation with a 5.46 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.56%
0%
3.56%
6 Months
-14.96%
0%
-14.96%
1 Year
24.27%
0%
24.27%
2 Years
28.02%
0%
28.02%
3 Years
69.58%
0%
69.58%
4 Years
62.03%
0%
62.03%
5 Years
0%
0%
0.0%
Philogen SpA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
60.53%
EBIT Growth (5y)
113.36%
EBIT to Interest (avg)
0.46
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.23
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.76%
ROE (avg)
7.92%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
5.46
EV to EBIT
17.83
EV to EBITDA
15.88
EV to Capital Employed
21.80
EV to Sales
7.47
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
122.30%
ROE (Latest)
34.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
74.00
23.10
220.35%
Operating Profit (PBDIT) excl Other Income
38.00
-7.20
627.78%
Interest
0.50
0.50
Exceptional Items
1.40
2.20
-36.36%
Consolidate Net Profit
45.30
-6.20
830.65%
Operating Profit Margin (Excl OI)
460.50%
-468.30%
92.88%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 220.35% vs -2.53% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 830.65% vs -14.81% in Dec 2023
About Philogen SpA 
Philogen SpA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






